Misgav Newsletter Q4 2007
Volume 3 | Number 4
To complete a process that began in early 2007, we are pleased to unveil our new website. When we began our rebranding process, we made a conscious decision to save the website for last. With all of the other pieces in place (name, logo, brochure, exhibit booth), we were ready to turn our attention to the website.
Starting with material from our existing site, we reviewed, revised, redesigned, and restructured. We worked with Studio Oz to ensure that our new site design was consistent with our overall rebranded look. Other site highlights --
- We added a "rockin'" Flash on the home page to present who we are and what we do.
- We placed an "Investment Opportunities" box on the home page. Each month we will highlight companies that are in the process of searching for investments.
- We reorganized the News page according to news about Misgav and news of our portfolio companies.
- We refreshed our Companies page for easier navigation.
As 2007 year draws to a close, we wish our readers a healthy, happy, exciting, and prosperous 2008.
Steve Rhodes, CEO
Misgav Venture Accelerator
NEWS
Returns to Angel Investors Top VC Returns
A recent study sponsored by the Ewing Marion Kauffman Foundation concluded that the more expertise an angel investment group brings to bear on the investment, the higher the likelihood of success. The study cited three areas where the Misgav Venture Accelerator places great emphasis. Read Steve's summary of the Kauffman report.
Welcome to Our Newest Portfolio Companies
- Nephera is developing a kidney assist device for chronic kidney disease. Applying negative pressure surrounding the kidney is expected to increase renal perfusion, which is thought to have a therapeutic effect on diseased kidneys. Gill Bar-Yoseph is the company's CEO.
-
NeuroQuest develops diagnostic kits for the discovery of neurodegenerative diseases such as Alzheimer's disease and ALS. The kits will be based on the identification of specific markers for these diseases. Today, there are no diagnostic tests for neurodegenerative diseases, making early diagnosis difficult. The kits from NeuroQuest will facilitate early diagnosis, thereby improving the efficacy of treatments.
Lavi Cardiatec Takes 2nd Place in Life Science Competition
Congratulations to Lavi Cardiatec. The medical device company took second place in this year's Life Science Start-Up Competition. After an extensive selection process, 10 companies were chosen to present to investors. Steve Rhodes, Misgav's CEO, presented for Cardiatec as Avner Amir, Cardiatec's CEO, was in the States at the time. Learn more about Lavi Cardiatec.
BioPack Featured in Israel21c
Graduate company BioPack was the subject of a recent feature story in Israel21c. "Israeli natural pesticide protects crops with turmeric," by David Brinn, focused on Professor Fadel Mansour's discovery of the herb's natural insect-repellent qualities. BioPack produces insect-repellent sheets for use in agriculture and the food industry. Read the story about BioPack.
ETView Featured in Globes
ETView has been in the news recently as it seeks to raise additional money. A Misgav graduate, ETView has developed an intubation tube with an embedded miniature video camera at the tip. Read the full story about ETView. Immunovative CEO Published in Med Hypotheses
Congratulations to Dr. Michael Har-Noy, CEO of Immunovative Therapies, on the publication of his article, "The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?" Written with Professor Shimon Slavin, the article will be published in Med Hypotheses (2007). It describes a "'mirror' effect, providing a non-toxic means to elicit the effective immune-mediated anti-tumor effect of BMT [bone marrow/stem cell transplant] without the GVHD[graft vs. host disease] toxicity and without the requirement for a matched donor." Learn more about Immunovative.
ProIV Featured in LabMedica International ProIV's infusion/transfusion system was featured on the front page (top and center) of LabMedica International. The article is entitled "'Smart' System Prevents Errors In Transfusions And Infusions." Read the article. Learn more about ProIV. Virtual Ports Featured in Start-Up Magazine An article about Virtual Ports was featured in the October 2007 issue of Start-Up magazine. The article, written by Beth Gilbert, focused on the company's unique internal anchor for use during laparoscopic procedures. Learn more about Virtual Ports.
6 Misgav Companies Travel to Philadelphia Venture Conference
Six Misgav portfolio companies -- Flexicath, Headway, ID-U Biometrics, Lavi Cardiatec, Tagra, and Virtual Ports -- attended the Trendlines/WolfBlock Venture Conference in Philadelphia, Pennsylvania, on November 28. Each company had an opportunity to attend small group and panel discussions and present their company to Israel-focused investors. As Daphna Palti-Wasserman, CEO of ID-U wrote, it was a "very interesting, well organized and productive conference."
ANNOUNCEMENTS
Damp weather did not dampen the Misgav's team's recent day out. Staff and project managers enjoyed driving ATVs through the mud and participating in a spirited team-building exercise. See the photo gallery (PDF format). Welcome to our new bookkeeper Yonina Barnea. Yonina joins Melanie Davids and Iris Shdema in our Misgav office.
©2007 The Misgav Venture Accelerator. All rights reserved
|
